The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The fourth quarter witnessed significant strategic shifts by major financial institutions, with UBS Group AG reducing its stake in Broadridge Financial Solutions by 8.2% despite the firm raising its FY26 guidance. Fifth Third Bancorp also rebalanced its portfolio, slashing its Zoetis position by 54.8% while increasing its stake in Regeneron Pharmaceuticals by 27.9%. Adding to the institutional divestment trend, Intact Investment Management cut its investment in Merck & Co (MRK) by 8.8%. This reduction follows notable insider selling activity at Merck, with transactions exceeding $38 million. These maneuvers, which also included expanding holdings in Corteva and General Mills, highlight how major players are rotating capital based on financial performance, growth outlooks, and internal corporate signals.
Sign in to access this content
Sign In